AI assistant
Ajanta Pharma Ltd. — Share Issue/Capital Change 2020
May 20, 2020
59171_rns_2020-05-20_b909b6ec-df9f-415e-9c2b-29a95dbaf387.pdf
Share Issue/Capital Change
Open in viewerOpens in your device viewer
Ajanta House T +91 22 6606 1000 Charkop, Kandivli West, F +91 22 6606 1200 Mumbai 400 067 E [email protected] India W www.ajantapharma.com
==> picture [292 x 28] intentionally omitted <==
20[th] May 2020
| BSE LIMITEDPhiroze Jeejeebhoy TowersDalal Street,Mumbai – 400001Scrip Code: BSE – AJANTPHARM 532331 | National Stock Exchange of India,Exchange Plaza, 5thFloor, Plot no.C/1, G Block, Bandra Kurla Complex,Bandra (East), Mumbai – 400 051Scrip Code: NSE AJANTPHARM EQ |
|---|
Sub: Reg. 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Dear Sir/Madam,
This is to inform that the Nomination & Remuneration Committee of the Board has at its meeting held today granted options under Ajanta Pharma Share Based Incentive Plan 2019, detailed below:
| Sr. No. | Particulars |
|---|---|
| 1. | Total numberofoptions granted–3,000 |
| 2. | Numberofshares covered underoptions-1share per option |
| 3. | ExercisePeriod–One month from vesting date |
This is for your information and record.
Thanking You,
Yours faithfully,
Digitally signed by Gaurang Shah Gaurang DN: c=IN, o=Personal, postalCode=400067, st=Maharashtra, 2.5.4.20=1d8c8ae0e05c6f13f8d60a9b7ff7662531acfdb06af09a4bec4c2649b037be4e, serialNumber=9d1d29419515cfbaa98275f9 d32858031027555ad3cc2adc46f3bb5d366d Shah 2c27, cn=Gaurang Shah Date: 2020.05.20 16:51:14 +05'30' GAURANG SHAH AVP – Legal & Company Secretary
Corporate Identity Number – L24230MH1979PLC022059